Unknown

Dataset Information

0

Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity.


ABSTRACT: The tumor-specific chromosomal translocation product, PAX3::FOXO1, is an aberrant fusion protein that plays a key role for oncogenesis in the alveolar subtype of rhabdomyosarcoma (RMS). PAX3::FOXO1 represents a validated molecular target for alveolar RMS and successful inhibition of its oncogenic activity is likely to have significant clinical applications. Even though several PAX3::FOXO1 function-based screening studies have been successfully completed, a directly binding small-molecule inhibitor of PAX3::FOXO1 has not been reported. Therefore, we screened small-molecule libraries to identify compounds that were capable of directly binding to PAX3::FOXO1 protein using surface plasmon resonance technology. Compounds that directly bound to PAX3::FOXO1 were further evaluated in secondary transcriptional activation assays. We discovered that piperacetazine can directly bind to PAX3::FOXO1 protein and inhibit fusion protein-derived transcription in multiple alveolar RMS cell lines. Piperacetazine inhibited anchorage-independent growth of fusion-positive alveolar RMS cells but not embryonal RMS cells. On the basis of our findings, piperacetazine is a molecular scaffold upon which derivatives could be developed as specific inhibitors of PAX3::FOXO1. These novel inhibitors could potentially be evaluated in future clinical trials for recurrent or metastatic alveolar RMS as novel targeted therapy options.

Significance

RMS is a malignant soft-tissue tumor mainly affecting the pediatric population. A subgroup of RMS with worse prognosis harbors a unique chromosomal translocation creating an oncogenic fusion protein, PAX3::FOXO1. We identified piperacetazine as a direct inhibitor of PAX3::FOXO1, which may provide a scaffold for designing RMS-specific targeted therapy.

SUBMITTER: Nakazawa K 

PROVIDER: S-EPMC10557868 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity.

Nakazawa Kay K   Shaw Taryn T   Song Young K YK   Kouassi-Brou Marilyn M   Molotkova Anna A   Tiwari Purushottam B PB   Chou Hsien-Chao HC   Wen Xinyu X   Wei Jun S JS   Deniz Emre E   Toretsky Jeffrey A JA   Keller Charles C   Barr Frederic G FG   Khan Javed J   Üren Aykut A  

Cancer research communications 20231001 10


The tumor-specific chromosomal translocation product, PAX3::FOXO1, is an aberrant fusion protein that plays a key role for oncogenesis in the alveolar subtype of rhabdomyosarcoma (RMS). PAX3::FOXO1 represents a validated molecular target for alveolar RMS and successful inhibition of its oncogenic activity is likely to have significant clinical applications. Even though several PAX3::FOXO1 function-based screening studies have been successfully completed, a directly binding small-molecule inhibit  ...[more]

Similar Datasets

2023-09-12 | GSE242690 | GEO
| PRJNA1014122 | ENA
| S-EPMC3982124 | biostudies-literature
| S-EPMC10894237 | biostudies-literature
| S-EPMC4373809 | biostudies-literature
| S-EPMC9166405 | biostudies-literature
| S-EPMC5982774 | biostudies-literature
2023-12-31 | GSE219199 | GEO
| S-EPMC5437248 | biostudies-literature
| S-EPMC5960625 | biostudies-literature